AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...
“Each pod has its own ventilation unit, USB and USB-C charging, and its own reading light,” says Jeremy O’Brien, Air New ...
US FDA approves AstraZeneca’s Baxfendy, an aldosterone synthase inhibitor to treat adults with hypertension: Cambridge, UK Wednesday, May 20, 2026, 10:00 Hrs [IST] AstraZenecas ...
Sneak peek at upcoming San Diego-area street fairs, festivals, concerts, performances, art shows, library events, community ...
Life Sciences Revenue -- $1.6 million, decreasing 48.4%, with R2 segment revenue mainly impacted by declines in Glacial FX ...
Barre3's women-centric approach guides CEO Sadie Lincoln in all of her decisions—whether that means bringing in a new brand ...
MarketBeat on MSN
British Land H2 Earnings Call Highlights
Key Points Interested in British Land Company PLC? Here are five stocks we like better. Leasing momentum is strong across British Land's London campuses and retail parks, with record campus leasing, ...
Here at Men's Journal, our team of editors and writers are constantly testing the latest gear and cool gadgets to find the ...
BioInvent International (STO:BINV)24% confirmed ORR (including complete response) in heavily pretreated patients (n=25) with advanced ovarian cancer who received BI-1808 and KEYTRUDA - multiplying by ...
KGET sent the candidates running for the 22nd Congressional District seat a questionnaire hoping to get answers to some basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results